Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Arne M. Ruder"'
Autor:
Miriam Eckl, Gustavo R. Sarria, Sandra Springer, Marvin Willam, Arne M. Ruder, Volker Steil, Michael Ehmann, Frederik Wenz, Jens Fleckenstein
Publikováno v:
Radiation Oncology, Vol 16, Iss 1, Pp 1-13 (2021)
Abstract Background Hypofractionation is increasingly being applied in radiotherapy for prostate cancer, requiring higher accuracy of daily treatment deliveries than in conventional image-guided radiotherapy (IGRT). Different adaptive radiotherapy (A
Externí odkaz:
https://doaj.org/article/60185fdb44e246b6b3edb3ee43e08a94
Autor:
Frederic Bludau, Grit Welzel, Tina Reis, Yasser Abo-Madyan, Elena Sperk, Frank Schneider, Sven Clausen, Arne M. Ruder, Udo Obertacke, Maged M. Ghaly, Frederik Wenz, Frank A. Giordano
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-7 (2019)
Abstract Background The spine is the most frequent location of bone metastases. Local treatment aims at palliation of pain and, given the increased likelihood of long-term cancer survival, at local control. Kyphoplasty and intraoperative radiotherapy
Externí odkaz:
https://doaj.org/article/f219c14bf4fd4ebe92952b7e264df24d
Autor:
Stefan Janssen, Rami A. El Shafie, Arne M. Ruder, Daniel Buergy, Davide Scafa, Frank A. Giordano, Nils H. Nicolay, Marco M. E. Vogel, Stephanie E. Combs, Fabian B. Fahlbusch, Dirk Rades, Lukas Käsmann
Publikováno v:
Strahlentherapie und Onkologie. 199:337-349
Purpose To review existing scientific literature on mobile applications (apps) in the field of radiation oncology and to evaluate characteristics of commercially available apps across different platforms. Methods A systematic review of the literature
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::684f3ee532a8ed3cafb8d6e4d3c7b373
https://doi.org/10.1007/s00066-023-02048-y
https://doi.org/10.1007/s00066-023-02048-y
Autor:
Thomas Büttner, Marielena K. E. Maerevoet, Frank A. Giordano, Marlon R. Veldwijk, Carsten Herskind, Arne M. Ruder
Background Ionotropic glutamate receptors AMPAR and NMDAR modulate proliferation, invasion and radioresistance in glioblastoma (GB). Pharmacological targeting is difficult as many in vitro-effective agents are not suitable for in patient applications
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a778aba7953bd398cb0925f7ad5b1ba0
https://doi.org/10.21203/rs.3.rs-2752583/v1
https://doi.org/10.21203/rs.3.rs-2752583/v1
